Huber Needles Market Share

Regionally, the global huber needles market is studied into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. Amongst these markets, the market in North America is projected to hold the largest huber needles market share by the end of 2037 backed by the significant propagation in chemotherapy and dialysis processes on account of major surge in lifestyle diseases, such as, diabetes, along with increasing count of various chronic disorders. For instance, approximately 790,000 individuals in the United States developed ESKD, also widely recognized as an end-stage renal disease (ESRD), in 2020, with 75% were receiving dialysis and 30% receiving a kidney transplant.

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of huber needles is estimated at USD 55.27 million.

The huber needles market size was valued at USD 51.44 million in 2024 and is poised to cross USD 163.07 million by the end of 2037, registering more than 9.2% CAGR during the forecast period i.e., between 2025-2037. Rising prevalence of needle stick injuries in healthcare workers, global surge in HIV prevalence, and increasing ratio of obesity in people across the globe will drive the market growth.

North America industry is likely to hold majority revenue share by 2037, driven by significant propagation in chemotherapy and dialysis processes on account of major surge in lifestyle diseases, such as, diabetes, along with increasing count of various chronic disorders in the region.

The major players in the market include B. Braun Medical Inc, .ICU Medical, Inc., Baxter International, Inc., Nipro Medical Corporation, Becton, Dickinson and Company, AngioDynamics, Inc., Vygon SAS, EXELINT International, Co., Medtronic, Terumo Corporation.

Huber Needles Market Share